<DOC>
	<DOC>NCT02804087</DOC>
	<brief_summary>To evaluate the safety and performance of the MobiusHD system in subjects with resistant hypertension.</brief_summary>
	<brief_title>Controlling And Lowering Blood Pressure With the MobiusHDTM Device</brief_title>
	<detailed_description>This is a prospective, randomized, double-blind, sham-controlled, multi-center post market study investigating the efficacy and safety of MobiusHD System, and the efficacy of the MobiusHD device in lowering mean systolic 24-hour ABP in subjects with resistant hypertension.</detailed_description>
	<criteria>Aged 1870 years; Diagnosed with resistant hypertension; A mean systolic 24hour ABP of 135170 mmHg following at least 30 days on a stable antihypertensive medication regimen (no changes in medications or dose). A mean systolic 24hour ABP of 135170 mmHg after washout of all antihypertensive medications. Known or clinically suspected baroreflex failure or autonomic neuropathy Treatable cause of resistant hypertension Hypertension secondary to an identifiable and treatable cause other than sleep apnea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>